Background As the aging issue and increased elderly esophageal cancer (EC) patients, we
sought to study the clinical characteristics, treatment modality and outcomes of EC patients …

Introduction: Esophageal cancer is the eighth most common cancer globally and has the
sixth worst prognosis because of its aggressiveness and poor survival. Data regarding …

Results Fourteen patients were aged over 80 and 24 under 79 years. Complete treatment
compliance was obtained in 30 (78.9%) of the patients. Chemotherapy was terminated and …

The addition of surgery to chemoradiation for esophageal cancer has not shown a survival
benefit in randomized trials. Patients with more comorbidities or advanced age are more …

Simple Summary Esophageal cancer (EC) is one of the most common cancers worldwide,
with over 1.6 million new cases and 1.2 million deaths each year. There is insufficient data …

Background Data on the age-specific incidence of esophageal cancer are lacking. Our aim
was to investigate the age-stratified incidence, treatment, and survival trends of esophageal …

Results During the study period, 6,296 patients were identified, 31% of which received
chemotherapy and definitive RT. Median age was 62 years and median follow up was 9 …

Cisplatin-based concurrent chemoradiotherapy for patients with unresectable, locally
advanced esophageal squamous cell carcinoma (ESCC) is associated with significant …

AIMS: To compare the outcomes of stage-directed surgical therapy and chemoradiotherapy
(CRT) for oesophageal cancer and to determine if a significant age–treatment interaction …

Background The benefit of endoscopic treatment (ET) and esophagectomy for early
esophageal cancer (EC) has been sufficiently recognized. Radiotherapy (RT) is the main …